This randomized, double-blind, placebo-controlled trial evaluated the safety and efficacy of a transdermal testosterone patch for treating hypoactive sexual desire disorder (HSDD) in surgically menopausal women. Participants receiving testosterone therapy experienced a 67% increase in satisfying sexual activity compared to a 48% increase in the placebo group (p